Tripawds Podcast Episode #84: Dr. Robert Rebhun at UC Davis discusses the IL-15 Canine Cancer Immunotherapy Study about immunotherapy for cancer that has spread to the lungs of dogs with osteosarcoma or melanoma. On this episode of Tripawd Talk Radio we introduce a new feature for listeners. We will now be sharing the complete unabridged audio from video interviews we hold with veterinary oncologists, orthopedic surgeons, rehab therapists, and other pet health specialists. Find the edited videos and subscribe at https://youtube.com/tripawds. And, keep listening to Tripawd Talk for our unabridged discussions with experts about topics of importance to anyone with pets facing amputation or a limb cancer diagnosis.
We kick off this new segment with our recent visit to UC Davis Veterinary Medical Teaching Hospital. This is the first of four interviews we held with faculty there about the cutting edge work they are doing. Dr. Robert Rebhun is Associate Professor and Researcher in Surgical & Radiological Sciences at UC Davis. He is working on a new study about immunotherapy for cancer that has spread to the lungs of dogs with osteosarcoma or melanoma. Rene get the details about this IL-15 Study, and how it differs from the Interleuken-2 research that has been done. We’ll learn how this inhalation therapy is administered, and what Adoptive Cell Transfer means. This interview was recorded on October third, 2019. For complete details about the study and info about how to participate, please visit https://tri.pet/ucd-il15